Iga Swiatek failed a doping check and has accepted a one-month suspension.
Former world No. 1 Swiatek examined constructive for the banned substance trimetazidine (TMZ) final August.
Reigning Roland Garros champion Swiatek has already serve a part of a one-month suspension and will likely be eligible to return to motion for subsequent month’s Australian Open, the Worldwide Tennis Integrity Company introduced.
The Worldwide Tennis Integrity Company (ITIA) confirms Świątek has accepted a one-month suspension underneath the Tennis Anti-Doping Program, after testing constructive for the prohibited substance trimetazidine (TMZ) in an out-of-competition pattern in August 2024.
The ITIA accepted that the constructive check was attributable to the contamination of “a regulated non-prescription treatment (melatonin), manufactured and offered in Poland that the participant had been taking for jet lag and sleep points, and that the violation was due to this fact not intentional.”
The ITIA mentioned it reached that conclusion following interviews with the participant and their entourage, investigations, and evaluation from two WADA-accredited laboratories.
The 23-year-old Swiatek formally admitted the ADRV and accepted the sanction. Swiatek was provisionally suspended from September 12 till October 4, lacking three tournaments, which counts in the direction of the sanction, leaving eight days remaining. As well as, she additionally forfeits prize cash from the Cincinnati Open, the event immediately following the check.
Assertion from the WTA:
The WTA acknowledges the choice by the Worldwide Tennis Integrity Affiliation (ITIA) – which administers the Tennis Anti-Doping Program (TADP) – in issuing a one-month suspension to Iga Swiatek, following the identification of a contaminated…
— wta (@WTA) November 28, 2024
The announcement means each males’s world No. 1 Jannik Sinner and former girls’s No. 1 Swiatek failed doping checks this season.
